Signaturefd, LLC Phathom Pharmaceuticals, Inc. Transaction History

Signaturefd, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 27, 2023	SELL	$9.18 - $11.53 $1,762 - $2,213	-192 Reduced 88.89%	24 $0
Q3 2022 Nov 08, 2022	BUY	$6.46 - $12.11 $956 - $1,792	148 Added 217.65%	216 $2,000
Q2 2022 Aug 10, 2022	SELL	$6.2 - $15.5 $204 - $511	-33 Reduced 32.67%	68 $1,000
Q1 2022 May 02, 2022	BUY	$11.55 - $20.06 $1,166 - $2,026	101 New	101 $1,000

144

73.6M

42.3K

45.7K

Ticker PHAT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,175,200
Market Cap $292M
Description
Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.